Please login to the form below

Not currently logged in
Email:
Password:

Novacyt strengthens group with senior hire

Paul Eros joins as commercial director

Clinical diagnostics specialist Novacyt has appointed Paul Eros as its commercial director of Primerdesign, a role that will see him focus on building its business-to-business pipeline.

Following 30 years’ experience within the field of molecular diagnostics, including strategic global marketing, sales and product management, Eros joins the French group from DiaSorin, where he was vice president of molecular marketing.

Graham Mullis, Group CEO at Novacyt, said: “Paul’s considerable blue-chip commercial expertise specifically in molecular diagnostics will be hugely beneficial as we aim to convert our healthy pipeline of clinical projects and B2B opportunities into new contracts.

“I am confident that we have invested in a strong senior leadership team that can continue to drive growth from the many opportunities that we see.”

Eros completes Novacyt’s investment in its senior commercial leadership team, building on the earlier appointments of Ruth Powell as managing director of the NovaPrep division and Phil Sefton as managing director of LAB21 Products.

11th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics